Evidence map›Paper›PMID 38981062›Full record

ArticleACS synthetic biology2024

Metabolic Profile of the Genome-Reduced

Rocío Aguilar Suárez, Michael Kohlstedt, Ayşegül Öktem, Jolanda Neef, Yuzheng Wu, Kaiya Ikeda, Ken-Ichi Yoshida, Josef Altenbuchner, Christoph Wittmann, Jan Maarten van Dijl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS synthetic biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Development of Bacillus subtilis cell factories for nutraceuticals production.World journal of microbiology & biotechnology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rocío Aguilar SuárezDepartment of Medical Microbiology, University Medical Center Groningen-University of Groningen, 9700RB Groningen, The Netherlands.ORCID 0000-0003-4452-065X
Michael KohlstedtInstitute for Systems Biotechnology, Saarland University, 66123 Saarbrücken, Germany.
Ayşegül ÖktemDepartment of Medical Microbiology, University Medical Center Groningen-University of Groningen, 9700RB Groningen, The Netherlands.
Jolanda NeefDepartment of Medical Microbiology, University Medical Center Groningen-University of Groningen, 9700RB Groningen, The Netherlands.
Yuzheng WuDepartment of Science, Technology and Innovation, Kobe University, 657-8501 Kobe, Japan.
Kaiya IkedaDepartment of Science, Technology and Innovation, Kobe University, 657-8501 Kobe, Japan.
Ken-Ichi YoshidaDepartment of Science, Technology and Innovation, Kobe University, 657-8501 Kobe, Japan.
Josef AltenbuchnerInstitute for Industrial Genetics, University of Stuttgart, 70569 Stuttgart, Germany.
Christoph WittmannInstitute for Systems Biotechnology, Saarland University, 66123 Saarbrücken, Germany.
Jan Maarten van DijlDepartment of Medical Microbiology, University Medical Center Groningen-University of Groningen, 9700RB Groningen, The Netherlands.ORCID 0000-0002-5688-8438

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Gram-positive bacterium

Indexed as

Bacillus subtilisGenome, BacterialRecombinant ProteinsBacterial ProteinsBioreactorsMetabolic EngineeringMetabolomeBacterial ProteinsRecombinant ProteinsBacillus subtilisenergetic parametersgenome reductionmetabolic features

Identifiers

PMID38981062
PMCPMC11264325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.